Srivastava T - Search Results

1

Inhibin Is a Novel Paracrine Factor for Tumor Angiogenesis and Metastasis.

Singh P, Jenkins LM, Horst B, Alers V, Pradhan S, Kaur P, Srivastava T, Hempel N, Győrffy B, Broude EV, Lee NY, Mythreye K. Singh P, et al. Among authors: srivastava t. Cancer Res. 2018 Jun 1;78(11):2978-2989. doi: 10.1158/0008-5472.CAN-17-2316. Epub 2018 Mar 13. Cancer Res. 2018. PMID: 29535220 Free PMC article.

2

Recent advances in targeted therapy for glioblastoma.

Mittal S, Pradhan S, Srivastava T. Mittal S, et al. Among authors: srivastava t. Expert Rev Neurother. 2015;15(8):935-46. doi: 10.1586/14737175.2015.1061934. Epub 2015 Jun 28. Expert Rev Neurother. 2015. PMID: 26118735 Review.

3

Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells.

Pradhan S, Mahajan D, Kaur P, Pandey N, Sharma C, Srivastava T. Pradhan S, et al. Among authors: srivastava t. Oncotarget. 2016 Nov 1;7(44):71841-71855. doi: 10.18632/oncotarget.12378. Oncotarget. 2016. PMID: 27708247 Free PMC article.

4

Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.

Pandey N, Tyagi G, Kaur P, Pradhan S, Rajam MV, Srivastava T. Pandey N, et al. Among authors: srivastava t. Cell Physiol Biochem. 2020 Aug 19;54(4):748-766. doi: 10.33594/000000253. Cell Physiol Biochem. 2020. PMID: 32809300 Free article.

5

Nucleic acid binding properties of allicin: spectroscopic analysis and estimation of anti-tumor potential.

Tyagi G, Pradhan S, Srivastava T, Mehrotra R. Tyagi G, et al. Among authors: srivastava t. Biochim Biophys Acta. 2014 Jan;1840(1):350-6. doi: 10.1016/j.bbagen.2013.09.007. Epub 2013 Sep 13. Biochim Biophys Acta. 2014. PMID: 24041991

6

Single-wall carbon nanotube based electrochemical immunoassay for leukemia detection.

Gulati P, Kaur P, Rajam MV, Srivastava T, Mishra P, Islam SS. Gulati P, et al. Among authors: srivastava t. Anal Biochem. 2018 Sep 15;557:111-119. doi: 10.1016/j.ab.2018.07.020. Epub 2018 Jul 23. Anal Biochem. 2018. PMID: 30048629

7

Inter-alu PCR detects high frequency of genetic alterations in glioma cells exposed to sub-lethal cisplatin.

Srivastava T, Seth A, Datta K, Chosdol K, Chattopadhyay P, Sinha S. Srivastava T, et al. Int J Cancer. 2005 Nov 20;117(4):683-9. doi: 10.1002/ijc.21057. Int J Cancer. 2005. PMID: 15912534

8

Sensitizing glioma cells to cisplatin by abrogating the p53 response with antisense oligonucleotides.

Datta K, Shah P, Srivastava T, Mathur SG, Chattopadhyay P, Sinha S. Datta K, et al. Among authors: srivastava t. Cancer Gene Ther. 2004 Aug;11(8):525-31. doi: 10.1038/sj.cgt.7700724. Cancer Gene Ther. 2004. PMID: 15167899

9

Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.

Jha P, Agarwal S, Pathak P, Srivastava A, Suri V, Sharma MC, Chosdol K, Srivastava T, Gupta D, Gupta A, Suri A, Sarkar C. Jha P, et al. Among authors: srivastava t, srivastava a. Cancer Genet Cytogenet. 2010 Apr 15;198(2):126-34. doi: 10.1016/j.cancergencyto.2009.12.018. Cancer Genet Cytogenet. 2010. PMID: 20362227

10

Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors.

Chosdol K, Misra A, Puri S, Srivastava T, Chattopadhyay P, Sarkar C, Mahapatra AK, Sinha S. Chosdol K, et al. Among authors: srivastava t. BMC Cancer. 2009 Jan 7;9:5. doi: 10.1186/1471-2407-9-5. BMC Cancer. 2009. PMID: 19126244 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

469 results

Search Page

Filters